Power Law company profile

10X Genomics

Biotech & Life Sciences · Pleasanton, United States · Founded 2012 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.17B

Market cap · Apr/2026

Revenue

$643M

Latest reported FY

Investors

10 investors on 10X Genomics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 10 investors entered at this stage

SoftBank Vision Fund

Sophia Genetics

Wells Fargo Capital Finance

Paladin Capital Group

Global footprint

Where 10X Genomics has talent and traffic

AI talent share

0.3% of workforce is AI talent
(8 of 2,311 staff)

Core AI20.09%

Other AI60.26%

Non-AI workforce2,30399.65%

Web traffic by country

280K monthly visits
across markets

🇺🇸 United States32.5%

🏳️ Korea6.8%

🏳️ Republic of5.2%

🇻🇳 Vietnam4.7%

🇯🇵 Japan4.1%

Top 5 markets shown

Patent intelligence

$219M patent portfolio · 557 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$219M

10.1% of market cap · 28.8× the top peer Sophia Genetics ($8M)

557 active patent families

Where 10X Genomics innovates Molecular biologyBioinformaticsBiological organismBiophysicsAnalyte

Tech-focus vs peers

Where 10X Genomics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across 10X Genomics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See 10X Genomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo